We show that miRNAs present in NF serum were protective and prevented the upregulation of pathologic markers, and that differentially regulated circulating proteins had likely contributed to pathological changes in gene expression in pediatric patients with DCM. The gene discussed is NFASC; the disease is familial dilated cardiomyopathy.